Deutsche Bank’s Coherus Oncology CHRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$121K Hold
71,762
﹤0.01% 3190
2025
Q4
$102K Sell
71,762
-46,221
-39% -$67.4K ﹤0.01% 3288
2025
Q3
$193K Hold
117,983
﹤0.01% 3076
2025
Q2
$86.1K Hold
117,983
﹤0.01% 3307
2025
Q1
$95.6K Buy
117,983
+78,508
+199% +$90.4K ﹤0.01% 3210
2024
Q4
$54.5K Hold
39,475
﹤0.01% 3399
2024
Q3
$41.1K Hold
39,475
﹤0.01% 3397
2024
Q2
$68.3K Sell
39,475
-86,038
-69% -$173K ﹤0.01% 3248
2024
Q1
$300K Sell
125,513
-1,006,726
-89% -$2.48M ﹤0.01% 2612
2023
Q4
$3.77M Buy
1,132,239
+1,090,063
+2,585% +$2.92M ﹤0.01% 1369
2023
Q3
$158K Buy
42,176
+12,417
+42% +$57.4K ﹤0.01% 2927
2023
Q2
$127K Sell
29,759
-19,990
-40% -$118K ﹤0.01% 3158
2023
Q1
$340K Sell
49,749
-280,232
-85% -$2.17M ﹤0.01% 2713
2022
Q4
$2.61M Sell
329,981
-348,122
-51% -$2.68M ﹤0.01% 1503
2022
Q3
$6.52M Sell
678,103
-2,530
-0.4% -$25.6K ﹤0.01% 1115
2022
Q2
$4.93M Buy
680,633
+264,818
+64% +$2.3M ﹤0.01% 1290
2022
Q1
$5.37M Sell
415,815
-4,531
-1% -$57.6K ﹤0.01% 1391
2021
Q4
$6.71M Sell
420,346
-265,132
-39% -$4.64M ﹤0.01% 1288
2021
Q3
$11M Sell
685,478
-149,111
-18% -$2.19M 0.01% 1119
2021
Q2
$11.5M Buy
834,589
+66,736
+9% +$945K 0.01% 1116
2021
Q1
$11.2M Buy
767,853
+168,044
+28% +$2.85M 0.01% 1136
2020
Q4
$10.4M Sell
599,809
-5,410
-0.9% -$96.3K 0.01% 1017
2020
Q3
$11.1M Sell
605,219
-147,463
-20% -$2.74M 0.01% 929
2020
Q2
$13.4M Buy
752,682
+237,359
+46% +$4.02M 0.01% 843
2020
Q1
$8.36M Buy
515,323
+10,206
+2% +$189K 0.01% 983
2019
Q4
$9.09M Buy
505,117
+306,291
+154% +$5.65M 0.01% 1134
2019
Q3
$4.03M Sell
198,826
-3,732
-2% -$74.6K ﹤0.01% 1509
2019
Q2
$4.47M Sell
202,558
-797,414
-80% -$13.8M ﹤0.01% 1887
2019
Q1
$13.6M Sell
999,972
-1,382,466
-58% -$18.4M 0.01% 1197
2018
Q4
$21.6M Buy
2,382,438
+457,326
+24% +$5.29M 0.02% 861
2018
Q3
$31.8M Buy
1,925,112
+609,573
+46% +$10.8M 0.02% 874
2018
Q2
$18.4M Buy
1,315,539
+631,718
+92% +$9.04M 0.01% 1239
2018
Q1
$7.55M Buy
683,821
+325,867
+91% +$3.57M ﹤0.01% 1861
2017
Q4
$3.15M Buy
357,954
+277,788
+347% +$2.97M ﹤0.01% 2409
2017
Q3
$1.07M Sell
80,166
-1,447
-2% -$19.1K ﹤0.01% 2961
2017
Q2
$1.17M Buy
81,613
+13,802
+20% +$265K ﹤0.01% 2915
2017
Q1
$1.43M Sell
67,811
-32,868
-33% -$809K ﹤0.01% 2438
2016
Q4
$2.83M Sell
100,679
-106,310
-51% -$2.97M ﹤0.01% 2033
2016
Q3
$5.54M Buy
206,989
+160,197
+342% +$4.37M ﹤0.01% 1664
2016
Q2
$788K Buy
46,792
+39,512
+543% +$742K ﹤0.01% 3049
2016
Q1
$153K Buy
7,280
+1,419
+24% +$23.2K ﹤0.01% 3778
2015
Q4
$134K Sell
5,861
-17,655
-75% -$454K ﹤0.01% 3913
2015
Q3
$471K Sell
23,516
-1,146
-5% -$34.9K ﹤0.01% 3388
2015
Q2
$711K Buy
24,662
+24,652
+246,520% +$623K ﹤0.01% 3189
2015
Q1
$0 Sell
10
-6,325
-100% -$163K ﹤0.01% 5181
2014
Q4
$103K Buy
+6,335
New +$89.4K ﹤0.01% 4699

Other funds holding CHRS